Suppr超能文献

二胺氧化酶活性与大鼠和豚鼠微血管内皮细胞的结合。与脂蛋白脂肪酶结合的比较。

Binding of diamine oxidase activity to rat and guinea pig microvascular endothelial cells. Comparisons with lipoprotein lipase binding.

作者信息

Robinson-White A, Baylin S B, Olivecrona T, Beaven M A

出版信息

J Clin Invest. 1985 Jul;76(1):93-100. doi: 10.1172/JCI111983.

Abstract

Microvascular endothelial cells from rat and guinea pig fat pads were shown to bind diamine oxidase (DAO) activity when incubated with soluble extracts of placenta (33 DAO U/mg of placenta) and a purified placental enzyme preparation (94 U/micrograms of protein). The extent of binding was dependent on the concentration of enzyme activity and tissue. Saturation of binding sites with 5,000 U of DAO/ml resulted in levels of bound activity (up to 11-13 U/mg of endothelial cells) in excess of that observed in all tissues except placenta. Scatchard plots suggested that there were at least two DAO binding sites (apparent Km 92 and 2,450 U/ml). Although the same cell preparations bound 125I-labeled lipoprotein lipase (LPL), the presence of LPL on the endothelial cell surface did not interfere with the binding of DAO activity except when cells were exposed to high concentrations of LPL. Alternatively, bound DAO activity was partially displaced (up to 33%) only with high concentrations (30 micrograms/ml) of LPL. DAO activity may thus be bound to at least two populations of sites, one of which may bind LPL. Both enzymes, however, were displaced by heparin (0.05-5 U/ml) and DAO binding was impaired by prior treatment of cells with proteolytic and glycosaminoglycandegrading enzymes. The demonstration of DAO binding to vascular endothelial cells provides a further example of the ability of these cells to bind enzymes at their surface and thereby act on biologically active substances in the circulation.

摘要

当与胎盘的可溶性提取物(33道氏单位/毫克胎盘)和纯化的胎盘酶制剂(94单位/微克蛋白质)一起孵育时,大鼠和豚鼠脂肪垫的微血管内皮细胞显示出结合二胺氧化酶(DAO)活性。结合程度取决于酶活性和组织的浓度。用5000单位/毫升的DAO饱和结合位点,导致结合活性水平(高达11 - 13单位/毫克内皮细胞)超过除胎盘外所有组织中观察到的水平。Scatchard图表明至少有两个DAO结合位点(表观Km为92和2450单位/毫升)。虽然相同的细胞制剂结合125I标记的脂蛋白脂肪酶(LPL),但内皮细胞表面LPL的存在并不干扰DAO活性的结合,除非细胞暴露于高浓度的LPL。或者,只有高浓度(30微克/毫升)的LPL才能部分取代(高达33%)结合的DAO活性。因此,DAO活性可能与至少两种位点结合,其中一种可能结合LPL。然而,两种酶都被肝素(0.05 - 5单位/毫升)取代,并且蛋白酶和糖胺聚糖降解酶预先处理细胞会损害DAO结合。DAO与血管内皮细胞结合的证明进一步说明了这些细胞在其表面结合酶并从而作用于循环中的生物活性物质的能力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验